Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levemir in Cystic Fibrosis Related Diabetes
NCT00639626Phase 3Terminated
- Sponsor
- Nationwide Children's Hospital
- Start
- Aug 2008
- Primary completion
- May 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin detemir in cystic fibrosis-related diabetes (CFRD), sponsored by Nationwide Children's Hospital. Started Aug 2008; status: terminated.
02
Drugs
insulin detemir
03
Conditions
cystic fibrosis-related diabetes (CFRD)
Beyond the preview
Go deeper on NCT00639626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00639626.